Secreted factors from brain endothelial cells maintain glioblastoma stem‐like cell expansion through the mTOR pathway

[1]  K. Tachibana,et al.  Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells. , 2010, Neuro-oncology.

[2]  S. Rafii,et al.  Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells , 2010, Nature Cell Biology.

[3]  Nzhde Agazaryan,et al.  Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma , 2010, BMC Cancer.

[4]  T. Cloughesy,et al.  mTOR signaling in glioblastoma: lessons learned from bench to bedside , 2010, Neuro-oncology.

[5]  C. Daumas-Duport,et al.  CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors , 2010, BMC Cancer.

[6]  C. Brennan,et al.  Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. , 2010, Cell stem cell.

[7]  Tatsuya Ozawa,et al.  PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. , 2009, Cell stem cell.

[8]  G. Riggins,et al.  Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells , 2009, Molecular Cancer Therapeutics.

[9]  R. McLendon,et al.  Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition , 2008, Stem cells.

[10]  D. Koul.  PTEN Signaling pathways in glioblastoma , 2008, Cancer biology & therapy.

[11]  C. Cordon-Cardo,et al.  Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas. , 2008, Cancer research.

[12]  S. Leenstra,et al.  The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids , 2008, Oncogene.

[13]  P. Pandolfi,et al.  PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. , 2008, Genes & development.

[14]  Z. Werb,et al.  Location, location, location: the cancer stem cell niche. , 2007, Cell stem cell.

[15]  R. Gilbertson,et al.  Making a tumour's bed: glioblastoma stem cells and the vascular niche , 2007, Nature Reviews Cancer.

[16]  D. Hicklin,et al.  Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. , 2007, Cancer research.

[17]  P. Sánchez,et al.  HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity , 2007, Current Biology.

[18]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[19]  G. Broggi,et al.  Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells , 2006, Nature.

[20]  M. Ginsberg.  Faculty Opinions recommendation of VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. , 2006 .

[21]  Daniel J. Hoeppner,et al.  Notch signalling regulates stem cell numbers in vitro and in vivo , 2006, Nature.

[22]  Angelo L. Vescovi,et al.  Brain tumour stem cells , 2006, Nature Reviews Cancer.

[23]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[24]  J. Greenwood,et al.  Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  D. Farkas,et al.  Isolation of cancer stem cells from adult glioblastoma multiforme , 2004, Oncogene.

[26]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[27]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[28]  F. Davis,et al.  Epidemiology of brain tumors. , 2000, Current opinion in neurology.

[29]  H. Hanafusa,et al.  The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Tracy T Batchelor,et al.  AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. , 2007, Cancer cell.

[31]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.